Showing results for isu fsgs
Each year 8,000 Americans are diagnosed with Nephrotic Syndrome, contributing to the millions currently living with some form of chronic kidney disease. It also means there are 8,000 more reasons … Read more
Kidney Health for All – that is this year’s theme for World Kidney Day. In celebration of this ideal, and recognition of everyone impacted by the many forms of Chronic … Read more
One of the most important things we do at NephCure is connect people to others experiencing similar challenges of living with chronic kidney disease. Whether it be understanding the complexity … Read more
The Levine family just took great steps to STAND UP & BE COUNTED. Meeting with the Congressman, they took just another step for the best representation and advocation for those … Read more
Houston, TX (November 10, 2015) – The NephCure Kidney Walk returns to the Houston area this Saturday, November 14th to a new location in The Woodlands. The walk brings together … Read more
Hi, my name is Amanda, I’m an attorney, live in Chicago, and I have FSGS. When I was 26 I began gaining weight unexpectedly and a kidney biopsy a couple … Read more
When schools are no longer session, NephCure Kidney International opens its doors to fresh, new faces for internship opportunities. It’s standard protocol to not only give these students professional work … Read more
Juli Millas is an FSGS patient living in the Central Florida area, who was first diagnosed in July 2002. She has built a strong sense of community within her region … Read more
Kevin Mott is an FSGS patient living in the Chicago area. Early on, he had a tough time finding doctors who would take his symptoms seriously. He saw four medical … Read more
Christopher Windisch is an FSGS patient living in the Southern California area. His leadership has helped secure not only a great sense of support and friendship within the local kidney … Read more
Levine succeeds NephCure co-founder Irving Smokler in the position KING OF PRUSSIA, Pa. (June 15, 2021) — NephCure Kidney International (NephCure) announced today the election of longtime volunteer and board … Read more
Interim results have been announced from Travere Therapeutic’s PROTECT study, and although preliminary, the data look promising for IgA Nephropathy (IgAN) patients. Travere’s ongoing Phase 3 trial is studying the … Read more
NephCure is a registered non-profit (501c3) tax-exempt charitable organization. EIN # 38-3569922.
© Copyright 2024 NephCure, Inc. All rights reserved worldwide. NephCure, and the logo, are federally registered trademarks of NephCure, Inc.
EN 
ES 